Advancements in the Controlled Delivery of Nanomedicines to the Central Nervous System: Challenges and Innovations
According to the World Health Organization (WHO), about 20% of people suffer from central nervous system (CNS) disorders such as cerebral cancer, depression, Parkinson’s, Alzheimer’s, dementia, epilepsy, str...
- Submission status
- Open
- Submission deadline
- 31 December 2024